Products - Lipid disorders | Topic

Showing 5 products

Date | Title

Cardiovascular risk assessment and lipid modification
Status:
In development
Expected publication date:
23 July 2025
VTS-270 for treating Niemann-Pick type C1 [ID1267]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
TBC
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
TBC
Olipudase alfa for treating Niemann-Pick disease types A and B [ID3913 ]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
TBC
Venglustat for treating gangliosidoses in people 2 years and over ID 6358
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC